Forget the Headlines — Anavex (AVXL)’s Alzheimer’s Drug Could Change Everything
Anavex Life Sciences Corporation (NASDAQ:AVXL), is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for…
From Penny Stock to Powerhouse? AIM ImmunoTech (AIM)’s Comeback Could Be Epic
AIM ImmunoTech Inc. (NYSE:AIM) traces its roots to 1966, when the company—then known as Hemispherx Biopharma—set out to…
GlaxoSmithKline (GSK)’s Reinvention is Complete—Will This Drug Giant Deliver 50% Upside in 2025?
GlaxoSmithKline plc (NYSE:GSK), commonly referred to as GSK, is a global biopharmaceutical powerhouse headquartered in the United Kingdom…
Abeona (ABEO) Could Be Wall Street’s Next Biotech Darling
Abeona Therapeutics Inc. (NASDAQ:ABEO) is a commercial-stage biopharmaceutical company pioneering the development of gene and cell therapies for…
Pelthos Therapeutics (PTHS): Zero Debt, $50M in Cash, and an FDA Greenlight—What’s Not to Love?
Pelthos Therapeutics Inc. (NYSE:PTHS) is a newly minted, revenue-ready biopharmaceutical company that sprang to life on July 2,…
Biotech Bargain Alert: Theravance Biopharma (TBPH) May Offer Triple-Digit Upside in 2025
Theravance Biopharma Inc. (NASDAQ:TBPH) is a clinical-stage biopharmaceutical company that has steadily built a reputation for its focus…
Artelo Biosciences (ARTL): The $10M Company Targeting Billion-Dollar Markets
Artelo Biosciences, Inc. (NASDAQ: ARTL) is a clinical-stage pharmaceutical company based in Solana Beach, California, pioneering a novel…
Wall Street Is Sleeping on Tempest Therapeutics (TPST)—But Not For Long
Tempest Therapeutics, Inc. (NASDAQ:TPST) is a 2011-founded, Brisbane-based oncology innovator that has quietly risen from a niche research…
Forget Daily Pills—Intellia Therapeutics (NTLA) is Creating Cures You Only Need Once
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a biotechnology company at the forefront of a genomic revolution, pioneering the development…
Nektar Therapeutics (NKTR) Skyrockets 350% in a Week!
Nektar Therapeutics (NASDAQ:NKTR) is a San Francisco-based biotechnology company that has spent over three decades pushing the boundaries…
Soleno Therapeutics (SLNO): The Biotech Company That Could Make You Rich
Soleno Therapeutics Inc. (NASDAQ:SLNO) is an innovative biotechnology company at the forefront of developing treatments for rare diseases…
Investing in Ultragenyx (RARE): The Biotech Stock With 100%+ Upside Potential
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is an innovative biotechnology company that has carved out a prominent position in the…
Exact Sciences (EXAS) Just Made Cancer Detection 100x Easier!
Exact Sciences Corporation (NASDAQ:EXAS) is a pioneering biotechnology company committed to improving the lives of patients through groundbreaking…
BioCryst (BCRX) is a Top Stock for Investors Focused on Rare Diseases
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), headquartered in Research Triangle Park, North Carolina, is a pioneering biotechnology company committed to…
Can Medtronic (MDT)’s MiniMed Spin-Off Unlock Billions? Wall Street Thinks So
Medtronic plc (NYSE:MDT) stands today as one of the world’s largest and most influential medical technology companies, yet…
Novo Nordisk (NVO)’s New Pill Promises Double-Digit Weight Loss—Could it Blow Up the GLP-1 Market?
Founded in 1923 and headquartered in Bagsværd, Denmark, Novo Nordisk A/S (NYSE:NVO) is a global healthcare company and…
XPro™ Could Be the Holy Grail in Alzheimer’s Treatment — And INmune Bio (INMB) Owns It
INmune Bio Inc. (NASDAQ:INMB)is a clinical-stage biotechnology company pioneering a new frontier in immunotherapy by targeting the innate…
Aurinia Pharmaceuticals (AUPH) Just Turned Profitable — Is This the Most Undervalued Biotech Stock of 2025?
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a late-stage biopharmaceutical company headquartered in Victoria, British Columbia, with U.S. commercial operations…